EnQuest PLC, +5,09%. Karo Pharma, +4,97% Episurf Medical B, -1,05%, 9 437 976 Media and Games Invest Plc, -3,10%, 26 205 790. Cibus Nordic Real

Collect stock market data. Price, volume, insider information, corporate actions etc. Perform advanced analysis. Using mathematical pattern recognition, statistical

To some, the recent pullback wouldn't be surprising after such a fast rise. DIAMYD MEDICAL AB chart This market's chart. This is a visual representation of the price action in the market, over a certain period of time. Go long or short on over 8000 share prices, get greater flexibility with direct market access and even buy shares outright.

Latest Share Price and Events Stable Share Price : DMYD B is more volatile than 75% of Swedish stocks over the past 3 months, typically moving +/- 10% a week. Diamyd Medical B quote is equal to 25.950 SEK at 2021-02-12. Based on our forecasts, a long-term increase is expected, the "DMYD-B" stock price prognosis for 2025-08-04 is 62.013 SEK. With a 5-year investment, the revenue is expected to be around +138.97%. 2021-03-25 22:15:00 Diamyd Medical AB: Diamyd Medical carries out a directed share issue and raises proceeds of SEK 60 million-7,23% | 42,0 MSEK Check out our latest analysis for Diamyd Medical . The Last 12 Months Of Insider Transactions At Diamyd Medical . Notably, that recent sale by Director Anders Essen-Möller was not the only time they sold Diamyd Medical shares this year. They previously made an even bigger sale of -kr1.2m worth of shares at a price of kr26.00 per share.

How has Diamyd Medical's share price performed over time and what events caused price changes?

Diamyd Medical AB (publ) Stock Chart and Share Price Forecast, Short-Term "DYMDF" Stock Prediction for Next Days and Weeks Walletinvestor.com Diamyd Medical AB (publ) (DYMDF) Forecast Chart, Long-Term Predictions for Next Months and Year: 2021, 2022

It is active in the field of pharmaceutical development and investments in stem cell and medical technology. The Company develops the diabetes vaccine, Diamyd, with the active glutamic acid decarboxylase (GAD) ingredient for the treatment and prevention of autoimmune diabetes. Learn about DMYD B (XSTO) with our data and independent analysis including price, star rating, valuation, dividends, and financials.

Here you will find financial calendar, reports, information about the share and corporate Shares. Percentage. Diamyd Medical AB. 2,998,703. 12.82. Anders Essen-Möller The current share price is available on Nasdaq First North website:.

Latest Share Price and Events Stable Share Price : DMYD B is more volatile than 75% of Swedish stocks over the past 3 months, typically moving +/- 9% a week. DIAMYD MEDICAL B share price in real-time (A1T90L / SE0005162880), charts and analyses, news, key data, turnovers, company data. DMN | Complete Diamyd Medical AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. DYMDF | Complete Diamyd Medical AB Series B stock news by MarketWatch.

Cibus Nordic Real Diamyd Medical är en av huvudägarna i stamcellsbolaget NextCell Stamcellsbolaget Nextcell - Spotlight Stock Market; Sas aktie flashback. Find the latest Diamyd Medical AB ser. B (DMYD-B.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.
Arthro therapeutics

We note that Diamyd Medical's TSR, at 365% is higher than its share price return of 225%. Diamyd Medical B quote is equal to 25.950 SEK at 2021-02-12. Based on our forecasts, a long-term increase is expected, the "DMYD-B" stock price prognosis for 2025-08-04 is 62.013 SEK. With a 5-year investment, the revenue is expected to be around +138.97%. DIAMYD MEDICAL AB (PUBL) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share DIAMYD MEDICAL AB (PUBL) | FIRST NORTH SWEDEN: DMYD B | FIRST NORTH SWEDEN Latest Diamyd Medical AB (DMYD B:STO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. 2021-01-20 DYMDF: Get the latest Diamyd Medical stock price and detailed information including DYMDF news, historical charts and realtime prices.

Diamyd Medical B Ord Shs : The latest share price. INTERACTIVE CHART DYMDF: Get the latest Diamyd Medical stock price and detailed information including DYMDF news, historical charts and realtime prices. When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose SSME.
Scan shipping tracking

Diamyd Medical is a Swedish clinical-stage diabetes company active in the field of pharmaceutical development. The share is listed on Nasdaq Stockholm First North (ticker: DMYD B). SWE

View more search results.

5 days ago Stockopedia rates Diamyd Medical AB as a Highly Speculative Sucker Stock . 1 brokers rate it as a 'Buy'. Click to view STO:DMYD B's

Once up and running, the Diamyd Medical AB (Stockholm NASDAQ, First North) is dedicated to find a cure for type 1 diabetes: first, the autoimmune inflammation need to be Köp aktier i Diamyd Medical B - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.

The shares are issued with the support of an authorization given at the recent Annual General Meeting to issue up to 600,000 shares. The price for the purchase was US$ 21 per share which corresponded to the current market price. Produkter. Diamyd Medical utvecklar kombinationsterapier för behandling av autoimmun diabetes i syfte att förebygga, fördröja eller stoppa den autoimmuna attacken på betacellerna genom att inducera tolerans mot GAD, ett av autoantigenen som kroppen presenterar vid autoimmun diabetes, och på så sätt bevara kroppens egen förmåga att producera insulin. Diamyd Medical AB Class B,DMYD B,ISIN: SE0005162880 - view the latest price,charts and performance information at AJ Bell Youinvest 2021-01-20 · Discover historical prices for DYMDF stock on Yahoo Finance.